Gypenoside L Regulates piR-hsa-2804461/FKBP8/Bcl-2 Axis to Promote Apoptosis and Inhibit Ovarian Cancer
|更新时间:2025-04-30
|
Gypenoside L Regulates piR-hsa-2804461/FKBP8/Bcl-2 Axis to Promote Apoptosis and Inhibit Ovarian Cancer
“The latest research has found that saponins L from Gynostemma pentaphyllum promote apoptosis of ovarian cancer cells through the piR-hsa-2804461 pathway, providing new ideas for the treatment of ovarian cancer.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 11, Pages: 98-106(2025)
DONG Yuanguang,SUN Yinying,YUAN Mingdian,et al.Gypenoside L Regulates piR-hsa-2804461/FKBP8/Bcl-2 Axis to Promote Apoptosis and Inhibit Ovarian Cancer[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):98-106.
DONG Yuanguang,SUN Yinying,YUAN Mingdian,et al.Gypenoside L Regulates piR-hsa-2804461/FKBP8/Bcl-2 Axis to Promote Apoptosis and Inhibit Ovarian Cancer[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):98-106. DOI: 10.13422/j.cnki.syfjx.20250413.
Gypenoside L Regulates piR-hsa-2804461/FKBP8/Bcl-2 Axis to Promote Apoptosis and Inhibit Ovarian Cancer
Exploring Molecular Mechanism of Gypenoside L against Ovarian Cancer Based on Ferroptosis Pathway Mediated by Mature-tRNA-Asp-GTC/ATF3-LPCAT3
Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Related Author
DONG Yuanguang
SONG Nan
ZHU Jingxuan
ZHAO Jiao
WANG Qun
SUN Xiaofei
WANG Jiaxin
ZHANG Hongda
Related Institution
Shenyang He's Eye Hospital Co. Ltd.
Liaoning Cancer Hospital & Institute
Liaoning University of Traditional Chinese Medicine
Liaoning Cancer Hospital
First Affiliated Hospital of Heilongjiang University of Chinese Medicine